Publication:
Highly recommended dose of MK4 for osteoporosis.

Simple item page
dc.contributor.authorNarong Bunyaratavejen_US
dc.contributor.authorNipat Kittimanonen_US
dc.contributor.authorThunchanok Jitiviraien_US
dc.contributor.authorBoonsom Tongthongthipen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-09-13T06:55:08Z
dc.date.available2018-09-13T06:55:08Z
dc.date.issued2009-09-01en_US
dc.description.abstractThe recommended dose of Menatretenone is 45 mg three times a day; however the compliant in daily practice is not convenient. This study shows the twice dose per day is inferior to the recommended dose. This study used the level of Gla protein in osteocalcin as a parameter for the comparison. The mean of three-time dose a day is 11.27 nanogram per milliliter while the mean of the other group is 6.07 nanogram per milliliter after the three-month treatment.en_US
dc.identifier.citationJournal of the Medical Association of Thailand = Chotmaihet thangphaet. Vol.92 Suppl5, (2009)en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-73349110435en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/27947
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=73349110435&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleHighly recommended dose of MK4 for osteoporosis.en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=73349110435&origin=inwarden_US

Files

Collections

Scopus 2006-2010